Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)

PLoS ONE

Volumn 12, Issue 5, 2017, Pages

  Cuttler, Carrie ^a   Spradlin, Alexander ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROCANNABINOL; CANNABIS;

ADULT; ALCOHOL USE DISORDERS IDENTIFICATION TEST; ARTICLE; BEHAVIOR DISORDER ASSESSMENT; CANNABIS ABUSE SCREENING TEST; CANNABIS USE; CANNABIS USE DISORDERS IDENTIFICATION TEST REVISED; CANNABIS USE PROBLEMS IDENTIFICATION TEST; CONTROLLED STUDY; CONVERGENT VALIDITY; DAILY SESSIONS FREQUENCY AGE OF ONSET AND QUANTITY OF CANNABIS USE INVENTORY; DISCRIMINANT VALIDITY; FACTOR ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARIJUANA SMOKING HISTORY QUESTIONNAIRE; ONSET AGE; PREDICTIVE VALIDITY; PSYCHOMETRY; RELIABILITY; TIMELINE FOLLOWBACK METHOD FOR MARIJUANA; CANNABIS SMOKING; EATING; MARIJUANA ABUSE; VALIDATION STUDY; YOUNG ADULT;

ADULT; CANNABIS; EATING; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; PSYCHOMETRICS; YOUNG ADULT;

EID: 85019731414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0178194     Document Type: Article

References (43)

1. Johnston L, O'Malley PM, Bachman JG, Schulenberg JE, Miech RA. Monitoring the future national survey results on drug use, 1975-2014: Volume 2, College students and adults age 19-55. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2015. 435 p. Available from: http://www.monitoringthefuture.org/pubs/monographs/mtf-vol2-2014.pdf
2. Okaneku J, Vearrier D, McKeever RG, LaSala GS, Greenberg MI. Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. Clin Toxicol. 2015 Mar 16; 53(3):151-155.
3. Substance Abuse and Mental Health Services Administration. Behavioral Health in the United States: Results from the 2014 National Health Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. 37 p. Available from: http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf
4. Annaheim B. Who is smoking pot for fun and who is not? An overview of instruments to screen for cannabis-related problems in general population surveys. Addict Res Theory. 2013 Oct 1; 21(5):410-28.
5. López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 2015 Apr 1; 45(06):1121-33.
6. Sobell LC, Sobell MB, Buchan G, Cleland PA, Fedoroff I, Leo GI. The reliability of the Timeline Followback method applied to drug, cigarette, and cannabis use. 30th Annual Meeting of the Association for Advancement of Behavior Therapy, New York, 1996 Nov.
7. Fals-Stewart W, O'farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol. 2000 Feb; 68(1):134. PMID: 10710848
8. Robinson SM, Sobell LC, Sobell MB, Leo GI. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2014 Mar; 28(1):154. https://doi.org/10.1037/a0030992 PMID: 23276315
9. Bonn-Miller MO, Zvolensky MJ. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict. 2009 Aug 10; 18(5):409-16. https://doi.org/10.3109/10550490903077705 PMID: 19874161
10. Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, et al. "Time for dabs": Analyzing Twitter data on marijuana concentrates across the US. Drug Alcohol Depend. 2015 Oct 1; 155:307-11. https://doi.org/10.1016/j.drugalcdep.2015.07.1199 PMID: 26338481
11. Loflin M, Earleywine M. A new method of cannabis ingestion: the dangers of dabs?. Addict Behav. 2014 Oct 31; 39(10):1430-3. https://doi.org/10.1016/j.addbeh.2014.05.013 PMID: 24930049
12. Lilienfeld SO, Andrews BP. Development and preliminary validation of a self-report measure of psychopathic personality traits in noncriminal population. J Pers Assess. 1996 Jun 1; 66(3):488-524. https://doi.org/10.1207/s15327752jpa6603-3 PMID: 8667144
13. Creemers HE, Dijkstra JK, Vollebergh WA, Ormel J, Verhulst FC, Huizink AC. Predicting life-time and regular cannabis use during adolescence; the roles of temperament and peer substance use: the TRAILS study. Addiction. 2010 Apr 1; 105(4):699-708. https://doi.org/10.1111/j.1360-0443.2009. 02819.x PMID: 20148797
14. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology. 2004 May 1; 173(3-4):398-404. https://doi.org/10.1007/s00213-003-1719-0 PMID: 14722704
15. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology. 1999 Mar 18; 142(3):295-301. PMID: 10208322
16. Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranieira RR, et al. Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry. 2011 Jun; 198(6):442-447 https://doi.org/10.1192/bjp.bp.110.077479 PMID: 21628706
17. Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 2013 July 1; 4 (53):1-19.
18. Legleye S, Karila L, Beck F, Reynaud M. Validation of the CAST, a general population Cannabis Abuse Screening Test. J Subst Use. 2007 Jan 1; 12(4):233-42.
19. Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, et al. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010 Jul 1; 110(1):137-43.
20. Alexander D. A marijuana screening inventory (experimental version): description and preliminary psychometric properties. Am J Drug Alcohol Abuse. 2003 Jan 1; 29(3):619-46. PMID: 14510044
21. Bashford J, Flett R, Copeland J. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction. 2010 Apr 1; 105 (4):615-25. https://doi.org/10.1111/j.1360-0443.2009.02859.x PMID: 20403014
22. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993 Jun 1; 88(6):791-804. PMID: 8329970
23. th edition. Bostom, MA: Pearson, 2013. 1024 p.
24. Cerny BA, Kaiser HF. A study of a measure of sampling adequacy for factor-analytic correlation matrices. Multivariate Behav Res. 1977 Jan 1; 12(1):43-7. https://doi.org/10.1207/s15327906mbr1201-3 PMID: 26804143
25. Kaiser HF. An index of factorial simplicity. Psychometrika. 1974 Mar 1; 39(1):31-6.
26. Bartlett MS. Properties of sufficiency and statistical tests. Proceedings of the Royal Society of London. Series A, Mathematical and Physical Sciences. 1937 May 18:268-82.
27. th edition. Iowa, USA: Iowa State University Press, 1989. 503 p.
28. UCLA Statistical Consulting Group. Annotated SPSS Output: Factor Analysis [Internet]. Los Angeles, CA: UCLA Statistical Consulting Group; 2007 [cited 2016 Oct 13]. Available from: http://www.ats.ucla.edu/stat/spss/output/factor1.htm
29. Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas. 1960 Apr; 20 (1):141-51.
30. nd edition. New Jersey, USA: Lawrence Erlbaum Associates, 1992. 442 p.
31. th edition. Boston, MA: Allyn & Bacon, 2002. 400 p.
32. nd edition. New Jersey, USA: Erlbaum, 1988.
33. Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016 Mar 1; 73(3):292-7. https://doi.org/10.1001/jamapsychiatry.2015.3278 PMID: 26842658
34. Asbridge M, Duff C, Marsh DC, Erickson PG. Problems with the identification of 'problematic' cannabis use: Examining the issues of frequency, quantity, and drug use environment. Eur Addict Res. 2014 Aug 28; 20(5):254-67. https://doi.org/10.1159/000360697 PMID: 25196945
35. Martin CS, Clifford PR, Clapper RL. Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students. J Subst Abuse. 1992 Dec 31; 4(3):319-26. PMID: 1458048
36. Welte JW, Barnes GM. The relationship between alcohol use and other drug use among New York state college students. Drug Alcohol Depend. 1982 Jul 31; 9(3):191-9. PMID: 6981498
37. Alexander D, Leung P. The Marijuana Screening Inventory (MSI-X): Concurrent, convergent and discriminant validity with multiple measures. Am J Drug Alcohol Abuse. 2009 Jul 7; 32(3):351-378.
38. Simons J, Correia CJ, Carey KB, Borsari BE. Validating a five-factor Marijuana Motives Measure: Relations with use, problems, and alcohol motives. J Couns Psychol. 1998 Jul; 45(3):265-273.
39. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995-2014): Analysis of current data in the United States. Biol Psychiatry. 2016 Apr 1; 79(7):613-9. https://doi.org/10.1016/j.biopsych.2016.01.004 PMID: 26903403
40. Gray KM, Watson NL, Christie DK. Challenges in quantifying marijuana use. Am J Addict. 2009 Jan 1; 18(2):178-9. https://doi.org/10.1080/10550490902772579 PMID: 19283572
41. Cuttler C, Mischley LK, Sexton M. Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users. Cannabis Cannabinoid Res. 2016; 1(1)
42. Fairman BJ. Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug Alcohol Depend. 2016; 159:72-79 https://doi.org/10.1016/j.drugalcdep.2015.11.015 PMID: 26686277
43. Greenfield SF, O'Leary G. Sex differences in marijuana use in the United States. Harv Rev Psychiatry. 1999; 6:297-303. PMID: 10370436